Technology 43 of 266
Molecular biomarkers
9 EIC Accelerator winners build on Molecular biomarkers, 1% of the classified companies, in 1 sector and 2 industries.
9
Companies
1
Sectors
2
Industries
5
Countries
0%
Exits
11%
Show signs of scaling
Sectors
- Health9 (100%)
Industries
Companies per year of first award
2019
2020
2021
2022
2023
2024
- Molecular biomarkers
Show the numbers
| Companies | Molecular biomarkers | |
|---|---|---|
| 2019 | 1 | 1 |
| 2020 | 2 | 2 |
| 2021 | 2 | 2 |
| 2022 | 3 | 3 |
| 2023 | 1 | 1 |
| 2024 | 0 | 0 |
What happened to them (9 of 9 checked)
- Active7 (78%)
- Exit0 (0%)
- Failed2 (22%)
- Other0 (0%)
Signs of scaling
- Scaling1 (11%)
- Not scaling5 (56%)
- Scaling unclear3 (33%)
Keywords
- Ambulances
- Antibiotic stewardship
- Antimicrobial resistance
- Bacterial or viral infection
- Biomarker analysis
- Biopsy fluid
- Biopsy reduction
- Blood test
- Cancer screening
- Colorectal cancer
- COVID-19
- Digital PCR
- Early diagnosis
- Emergency departments
- Emergency medicine
- Endometrial cancer
- Enzyme activity probes
- Extracellular vesicles
- Glycomics
- Gynaecology
- Host response analysis
- Inflammation
- Large vessel occlusion
- Lateral flow
- MicroRNA
- Multiple sclerosis
- Neurology
- Oncology
- Prostate cancer
- Protein-protein interactions
- Proteomics
- Rapid testing
- Saliva test
- Single-cell analysis
- Stroke
- suPAR
- Women's health
All 9 companies using Molecular biomarkers
| Company | Project | Industry | Country | Cut-off | Funding | Status | Rasph |
|---|---|---|---|---|---|---|---|
| MiMARK Diagnostics, S.L. | WomECReshaping women's health through the understanding of gynecological fluids. WomEC: Antibody-based IVD test based on 5 novel protein biomarkers quantified in liquid biopsy | In vitro diagnostics | Spain | March 2023 | Grant first | Active | Deep dive |
| ABCDx SA | LVOCheckDiagnosis of large vessel occlusion (LVO) in acute stroke for improving access to treatment | In vitro diagnostics | Spain | October 2022 | Blended finance | Active | Deep dive |
| Actome GmbH | PICO-NGSFirst time ultra-sensitive and simultaneous quantification of proteins, interactions, and post-translational modifications in single cells to enable exponential growth in proteomics and interactomics | Life science tools | Germany | October 2022 | Blended finance | Insolvent | Deep dive |
| ALA Diagnostics, S.L. | ALA DIAGNOSTICS MS KITRevolutionising the diagnosis of multiple Sclerosis with the first bioinformatic diagnostic kit that allows early detection with a simple blood test | In vitro diagnostics | Spain | October 2022 | Grant first | Active | Deep dive |
| ADVANCED MARKER DISCOVERY SL | ColoDixEarly detection of colorectal cancer in blood based on latest generation biomarkers and Artificial Intelligence tools | In vitro diagnostics | Spain | October 2021 | Grant first | Active | Deep dive |
| GLYCANOSTICS SRO | ProSCANProstate cancer diagnostics using a non-invasive test based on innovative glycan-based scanning | In vitro diagnostics | Slovakia | June 2021 | Grant first | Active | Deep dive |
| SOMAPROBES SL | Corona-QuickRapid and easy- test for Coronavirus infections | In vitro diagnostics | Spain | March 2020 | Grant only | Insolvent | Deep dive |
| ViroGates A/S | RISCinCOVIDOptimal use of hospital resources and intervention using suPAR for improving prognosis and care for patients with COVID-19 | In vitro diagnostics | Denmark | March 2020 | Grant only | Active | Deep dive |
| MEMED DIAGNOSTICS LTD | DECODEreDucing the health and Economic COst of Diagnostic uncErtainty: launch and randomized control trial of the first validated bacterial versus viral test | In vitro diagnostics | Israel | June 2019 | Grant only | Active | Deep dive |